T Cell News and Research

Latest T Cell News and Research

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Adaptive Biotechnologies today announced that Blood, the Journal of the American Society of Hematology, published online an analysis of patient samples from the Intergroupe Francophone du Myéloma 2009 trial.

1 Oct 2018

Xenex LightStrike Germ-Zapping Robots help reduce infection rates at Martin Medical Center

Patient safety is a top priority at Martin Medical Center, which recently announced that it has seen a significant reduction in its Clostridium difficile (C.diff) infection rates since adopting Xenex LightStrike Germ-Zapping Robots as its environmental standard of care.

1 Oct 2018

International conference features cutting-edge research studies on cancer immunotherapy

The Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, to be held in New York, Sept. 30-Oct. 3, will feature cutting-edge research studies from around the world that endeavor to answer urgent questions in the field of cancer immunotherapy to advance progress more rapidly for patients.

1 Oct 2018

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Today the U.S. Food and Drug Administration permitted marketing of ClonoSEQ assay, a next generation sequencing-based test for minimal residual disease in patients with acute lymphoblastic leukemiaor multiple myeloma. MRD is a measure of the amount of cancer cells remaining in a person's bone marrow.

30 Sep 2018

$Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors$

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

A phase I clinical trial investigating the use of bacterial Clostridium novyi-NT spores as an injectable monotherapy had manageable toxicities and showed early clinical efficacy in patients with treatment-refractory solid tumor malignancies, according to data presented at the Fourth CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival, held Sept. 30-Oct. 3.

30 Sep 2018

New EU-funded project trials novel type of graft for replacement of aortic valves

The EU-funded project ARISE is trialing a novel type of graft for the replacement of aortic valves: it is using donated human heart valves that have been stripped of the donor’s cells to appease the recipient’s immune system.

29 Sep 2018

Researchers deplete key protein for DNA replication using protein degradation system

Researchers from Tokyo Metropolitan University and the FIRC Institute of Molecular Oncology in Italy have succeeded in depleting AND-1, a key protein for DNA replication, by using a recently developed conditional protein degradation system.

29 Sep 2018

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

The University of Birmingham has been awarded £1.78 million by the Wellcome Trust for research aimed at finding new therapies to treat diseases such as heart failure, diabetes and neurodegenerative disorders.

29 Sep 2018

Cancer undercuts ability of normal cells to consume glucose, finds study

Cancer needs energy to drive its out-of-control growth. It gets energy in the form of glucose, in fact consuming so much glucose that one method for imaging cancer simply looks for areas of extreme glucose consumption - where there is consumption, there is cancer.

29 Sep 2018

Scientists investigate effect of flu-causing virus on three lung-derived cell lines

Perhaps inspired by the annual 3 to 5 million cases of severe influenza worldwide, the Guinness World Record organization is advertising for individuals or organizations to attempt a record for the most people getting a flu awareness lesson at once.

29 Sep 2018

Researchers design new combination therapy for reducing NSCLC cell growth

Lung cancer is the leading cause of cancer death among men and women. About 85 percent of lung cancers are non-small cell lung cancer. For a handful of these patients, therapies that target specific genetic mutations are effective.

29 Sep 2018

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

The U.S. Food and Drug Administration today approved Libtayo (cemiplimab-rwlc) injection for intravenous use for the treatment of patients with metastatic cutaneous squamous cell carcinoma or locally advanced CSCC who are not candidates for curative surgery or curative radiation.

28 Sep 2018

Researchers create photoswitchable fluorescent proteins with optical properties

Researchers developed fluorescent proteins that can be controlled by orange and green light. These proteins will help to study processes in living cells. The work was supported by Russian Science Foundation grant, and the results were published in Nature Methods.

28 Sep 2018

Engineering organoids from stem cells to model retina diseases

Gray Camp joined the Institute of Molecular and Clinical Ophthalmology Basel as Group Leader in Single Cell Genomics. His group will combine single-cell genomic tools and retina and cerebral "organoids" to explore the development of the human visual system.

28 Sep 2018

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

A piece of research conducted by the Free Radicals and Oxidative Stress Group at the UPV/EHU's Faculty of Medicine and Nursing has deciphered the antitumor mechanism exerted by the plant Vismia baccifera, originally from the Amazonian region of Colombia, in human liver cancer cells.

28 Sep 2018

T Cell News and Research

Latest T Cell News and Research

New analysis confirms value of minimal residual disease as prognostic indicator in multiple myeloma

Xenex LightStrike Germ-Zapping Robots help reduce infection rates at Martin Medical Center

International conference features cutting-edge research studies on cancer immunotherapy

FDA permits marketing of ClonoSEQ assay to detect minimal residual disease in blood cancer patients

Bacterial therapy shows early clinical efficacy in patients with treatment-refractory solid tumors

New EU-funded project trials novel type of graft for replacement of aortic valves

Researchers deplete key protein for DNA replication using protein degradation system

UB receives £1.78 million to find new therapies for treating heart failure and diabetes

Cancer undercuts ability of normal cells to consume glucose, finds study

Scientists investigate effect of flu-causing virus on three lung-derived cell lines

Researchers design new combination therapy for reducing NSCLC cell growth

FDA approves first intravenous treatment for metastatic cutaneous squamous cell carcinoma

Researchers create photoswitchable fluorescent proteins with optical properties

Engineering organoids from stem cells to model retina diseases

Researchers decipher antitumor mechanism of Amazonian plant in human cancer cells

Researchers start to understand how to make lab-grown heart cells mature

Research reveals how critical oocyte quality control process works

Synthetic DNA vaccine targets proteins overexpressed in several types of cancer

Researchers develop unique, biofuel-powered sensor to prevent and diagnose diseases

Loyola announces plans to produce CAR-T cells for treating cancer

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in